GUIYANG, China, Sept. 20, 2024 /Xinhua-AsiaNet/– Congjiang County, southwest China’s Guizhou Province, home to many ethnic groups, inherits an ancient and charming traditional Chinese agriculture
Author: Adnan Shamim
UNESCO-listed rice-fish-duck ecosystem benefits SW China’s Guizhou
GUIYANG, China, Sept. 20, 2024 /Xinhua-AsiaNet/– Congjiang County, southwest China’s Guizhou Province, home to many ethnic groups, inherits an ancient and charming traditional Chinese agriculture
UNESCO-listed rice-fish-duck ecosystem benefits SW China’s Guizhou
GUIYANG, China, Sept. 20, 2024 /Xinhua-AsiaNet/– Congjiang County, southwest China’s Guizhou Province, home to many ethnic groups, inherits an ancient and charming traditional Chinese agriculture
Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone —
Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone —
Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone —
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in